rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Scilex Holding Company

SCLX · Nasdaq

Health CarePharmaceuticalsNot moving yet

SCLX stood above a rising 150-day average in 8 of the last 52 weekly readings, and has been out of that trend for the last 44 weeks. It is 52.6% below that average now. Pharmaceuticals: 34% of its 74 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 44
Industry in uptrend
34% -5 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$12.8M
Officials’ trades on record
0
Institutions holding
69 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 8 of 52 weeks.

22 Apr – 21 Oct
26%35%45%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$12.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months3
Buyers · sellers0 · 1
WhoDidSharesTraded
Henry JiExec Chair, CEO and Presidentsold650,000at $0.153817 Apr 2026filed 20 Apr 2026
Stephen Hoi MaCFO, COO and Secretarybought650,000at $0.153817 Apr 2026filed 20 Apr 2026
Henry JiExec Chair, CEO and Presidentbought3,250,000at $0.153816 Apr 2026filed 20 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders69+1 on the quarter
New · exited13 · 12
Reported value$5.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026301,292$2.4M+37,242+14.1%
BlackRock, Inc.added · filed 7 Aug 2026109,417$853K+6,621+6.4%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202645,822$357K+6,164+15.5%
JACOBS LEVY EQUITY MANAGEMENT, INCnew · filed 14 Aug 202641,163$321K+41,163
STATE STREET CORPunchanged · filed 7 Aug 202635,376$276K00.0%
UBS Group AGadded · filed 13 Aug 202633,376$260K+26,908+416.0%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 202633,064$258K-3,800−10.3%
CITADEL ADVISORS LLCnew · filed 14 Aug 202627,497$214K+27,497
Ashton Thomas Private Wealth, LLCadded · filed 29 Jul 202618,482$144K+493+2.7%
NORTHERN TRUST CORPadded · filed 13 Aug 202615,047$117K+14+0.1%
30 Jun 2024 – 30 Jun 2026
44075Jun 24Dec 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

SCLX Stock Acquisition JV LLC Company insider10% owner · last 3 Jul 20260 · 0
Henry Ji Company insiderExec Chair, CEO and President · last 17 Apr 20263 · 0
Stephen Hoi Ma Company insiderCFO, COO and Secretary · last 17 Apr 20262 · 0
Scilex Holding Co Company insider10% owner · last 30 Dec 20250 · 3
Dorman Followwill Company insiderDirector · last 8 Oct 20251 · 0
Jay Chun Company insiderDirector · last 8 Oct 20252 · 0
Yue Alexander Wu Company insiderDirector · last 8 Oct 20251 · 0
Jaisim Shah Company insiderDirector, Officer · last 18 Dec 20245 · 0
David Lemus Company insiderDirector · last 17 Oct 20241 · 0
Annu Navani Company insiderDirector · last 16 Aug 20240 · 0
Sorrento Therapeutics, Inc. Company insider10% owner · last 21 Sep 20230 · 1
Elizabeth Czerepak Company insiderOfficer · last 17 Jan 20230 · 0

Same industry

Government contracts

No federal award is tied to it.

From its SEC filings

Free cash flow marginFY 2025 · to 31 Dec 202512.2%
Research spendFY 2025 · to 31 Dec 202568.5%
Share count trendFY 2025 · to 3 Apr 202620.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$5.0M
Free cash flowFY 2025 · to 31 Dec 2025$3.7M

Analyst forecasts

No analyst forecasts yet.